Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000084

Chief Commercial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Edwards Larry Todd · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-24 Grant or award : show line 1 in the form +100,000 100,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-24 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X06/form4.xml…